The epidemiology of pain in Parkinson's disease

Defazio, Giovanni; Gigante, Angelo; Mancino, Paola; Tinazzi, Michele
April 2013
Journal of Neural Transmission;Apr2013, Vol. 120 Issue 4, p583
Academic Journal
Pain occurring in Parkinson's disease (PD) may affect a large proportion of patients. Based on the results of the methodologically more robust case-control studies that detected a significantly greater frequency of pain in PD patients than in control subjects, pain should now be considered as a non-motor symptom of PD. The heterogeneous quality of pain, the variable relationship of pain with parkinsonian motor signs, and the mixed response of pain to dopaminergic drugs suggest complex mechanisms for pain in PD. Some evidence raises the possibility of common mechanisms shared by pain patients, regardless of the clinical heterogeneity of pain and its variable relationship with motor signs.


Related Articles

  • Parkinson's Disease:Functional Concerns and Therapeutic Considerations. Spring, Tom; Rorke, Stafford // Clinical Exercise Physiology;Nov2000, Vol. 2 Issue 4, p176 

    Discusses information related to Parkinson's disease (PD) in the U.S. Impact of the condition on the motor ability of patients; Symptoms affecting the degeneration of dopaminergic neurons of the substantia nigra in the midbrain; Emergence of complementary and natural therapies for the treatment...

  • Laboratory assessments in the course of Parkinson's disease: a clinician's perspective. Müller, Thomas; Baas, Horst; Kassubek, Jan; Riederer, Peter; Urban, Peter; Schrader, Christoph; Reichmann, Heinz; Woitalla, Dirk; Gerlach, Manfred // Journal of Neural Transmission;Jan2016, Vol. 123 Issue 1, p65 

    Physicians, caregivers and patients themselves must be alert to the onset of and changes in motor and non-motor features during the course of Parkinson's disease (PD). Parallel laboratory routine assessments are necessary because of the evolving impairment of the general health status of the...

  • Mutant α-synuclein-induced degeneration is reduced by parkin in a fly model of Parkinson's disease. Haywood, Annika F. M.; Staveley, Brian E.; Hilliker, A. J. // Genome;May2006, Vol. 49 Issue 5, p505 

    Parkinson's disease (PD) patients show a characteristic loss of motor control caused by the degeneration of dopaminergic neurons. Mutations in the genes that encode α-synuclein and parkin have been linked to inherited forms of this disease. The parkin protein functions as a ubiquitin ligase...

  • Environmental and Familial Risk Factors of Parkinsons Disease: Case-Control Study. Sanyal, Jaya; Chakraborty, D. P.; Sarkar, Biswanath; Banerjee, Tapas Kumar; Mukherjee, Subhash Chandra; Ray, Bidhan Chandra; Rao, V. R. // Canadian Journal of Neurological Sciences;Sep2010, Vol. 37 Issue 5, p637 

    Background: While the cause of Parkinson's disease (PD) remains unknown, evidence suggests certain environmental factors, such as well water drinking, herbicides, pesticides exposure and neurotoxins, may trigger the chain of oxidative reactions culminating in the death of dopaminergic neurons in...

  • Ioflupane I-123 radionuklidinÄ—s kompiuterinÄ—s tomografijos vaizdinimo taikymo galimybÄ—s ekstrapiramidinių sutrikimų ir demencijų diferencinÄ—je diagnostikoje. Kaladytė-Lokominienė, R.; Vajauskas, D.; Sakalauskaitė-Juodeikienė, E. // Neurologijos Seminarai;2011, Vol. 15 Issue 4, p253 

    In strict application of clinical criteria of Parkinson's disease, clinical diagnosis corresponds to histopathological diagnosis in 93 % of cases. Retrospective studies show that a significant number of parkinsonian patients do not receive a distinct clinical diagnosis for at least 5 years....

  • Neuroprotection in Parkinson's Disease: a Multi-directional Genetic Strategy for Maximum Protection of Dopaminergic Neurons against Parkinsonian Toxicity. Gardaneh, Mossa; Panahi, Yasin; Shojaei, Sahar; Mazaheri-Tehrani, Elham; Maghsudi, Nader // Iranian Journal of Medical Hypotheses & Ideas;2010, Vol. 4, p1 

    The complex biology of Parkinson's disease and the obscure mechanism of dopaminergic cell death in the course of the disease indicate that multiple intracellular pathways and numerous crucial elements contribute to the demise of these neurons. Therefore, multi-factorial approaches would more...

  • Role of movement in long-term basal ganglia changes: implications for abnormal motor responses. Simola, Nicola; Morelli, Micaela; Frazzitta, Giuseppe; Frau, Lucia // Frontiers in Computational Neuroscience;Oct2013, p1 

    Abnormal involuntary movements (AIMs) and dyskinesias elicited by drugs that stimulate dopamine receptors in the basal ganglia are a major issue in the management of Parkinson's disease (PD). Preclinical studies in dopamine-denervated animals have contributed to the modeling of these abnormal...

  • Recovery From Experimental Parkinsonism by Semaphorin-guided Axonal Growth of Grafted Dopamine Neurons. Díaz-Martínez, N Emmanuel; Tamariz, Elisa; Díaz, N Fabián; García-Peña, Claudia M; Varela-Echavarría, Alfredo; Velasco, Iván // Molecular Therapy;Aug2013, Vol. 21 Issue 8, p1579 

    Cell therapy in animal models of Parkinson's disease (PD) is effective after intrastriatal grafting of dopamine (DA) neurons, whereas intranigral transplantation of dopaminergic cells does not cause consistent behavioral recovery. One strategy to promote axonal growth of dopaminergic neurons...

  • Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease. Tönges, Lars; Szegö, Éva M.; Hause, Patrizia; Saal, Kim-Ann; Tatenhorst, Lars; Koch, Jan Christoph; d`Hedouville, Zara; Dambeck, Vivian; Kügler, Sebastian; Dohm, Christoph P.; Bähr, Mathias; Lingor, Paul // Frontiers in Aging Neuroscience;Sep2014, Vol. 6, p1 

    The dopaminergic (DAergic) nigrostriatal tract has an intrinsic regenerative capacity which can be impaired in Parkinson's disease (PD). Alpha-synuclein (aSyn) is a major pathogenic component in PD but its impact on DAergic axonal regeneration is largely unknown. In this study, we expressed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics